Literature DB >> 2874393

Isolation of HTLV-I from cerebrospinal fluid of a patient with myelopathy.

S Hirose, Y Uemura, M Fujishita, T Kitagawa, M Yamashita, J Imamura, Y Ohtsuki, H Taguchi, I Miyoshi.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 2874393     DOI： 10.1016/s0140-6736(86)90081-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy.

Authors:  Y Ohara; Y Iwasaki; S Izumo; I Kobayashi; A Yoshioka
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis.

Authors:  Toshiaki Takahashi; Shigeki Takemoto; Katsuhito Kiyasu; Hiroshi Yamamoto; Toshikazu Tani; Isamu Miyoshi; Hirokuni Taguchi; Toshiaki Moriki; Emiko Miyazaki; Hideaki Enzan
Journal:  Rheumatol Int       Date:  2005-07-01       Impact factor: 2.631

3.  Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type I.

Authors:  P S Sarin; P Rodgers-Johnson; D K Sun; A H Thornton; O S Morgan; W N Gibbs; C Mora; G McKhann; D C Gajdusek; C J Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  HTLV-I-associated meningitis.

Authors:  T Yokota; M Yamada; T Furukawa; H Tsukagoshi
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

5.  Tropical spastic paraparesis associated with human T lymphotropic virus type I in an east African naturalised in Sweden.

Authors:  B Ryberg; J Blomberg; P J Klasse
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28

6.  Characterization of two human lymphoid cell lines producing human T-lymphotropic virus type I (HTLV-I) isolated from patients with HTLV-I-associated myelopathy or encephalopathy.

Authors:  J Iwata; T Oka; M Furihata; H Sonobe; K Matsubayashi; Y Uemura; I Miyoshi; Y Ohtsuki
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 7.  The myeloneuropathies of Jamaica.

Authors:  O St Clair Morgan
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

8.  Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro.

Authors:  T Akagi; Y Hoshida; T Yoshino; N Teramoto; E Kondo; K Hayashi; K Takahashi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.

Authors:  Michael S Mitchell; Ellen T Bodine; Shawn Hill; Gerald Princler; Patricia Lloyd; Hiroaki Mitsuya; Masao Matsuoka; David Derse
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

10.  Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.

Authors:  R S Smith; R B Naso; J Rosen; A Whalley; Y L Hom; K Hoey; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.